Nexus Medical is now part of Avanos Medical, a global medical technology company focused on delivering clinically superior medical device solutions that help patients get back to what matters. The acquisition was completed in September 2025 and reflects a shared commitment to improving patient care in critical and acute care environments.
By joining Avanos Medical, Nexus brings its trusted anti-reflux needleless connector technology together with Avanos’ scale, clinical expertise, and long-standing focus on evidence-based care. As part of Avanos’ Specialty Nutrition Systems portfolio, Nexus Medical benefits from broader infrastructure, expanded clinical education capabilities, and additional investment to support clinicians in high-acuity care settings, including NICU and PICU environments – strengthening our ability to support patient safety and clinical workflows.
What This Means for Our Customers
For current Nexus customers, continuity remains the priority. The Nexus TKO® product line and the patented, pressure-activated anti-reflux technology you rely on remain unchanged.
Effective April 1, 2026, Nexus business systems and operations will transition to Avanos Medical, including processes related to product ordering, availability, and customer support. This transition is designed to create a more streamlined and consistent experience over time. Current customers will receive targeted communications for updates related to the integration. For questions regarding this transition, please contact TransitionQuestions@avanos.com.
If you have questions about products, orders, or support, please contact your Nexus Medical representative or visit our Contact Us page.
